Study Stopped
COVID-19 Pandemic
Maladaptive Adipose Tissue Activity in Cancer
4 other identifiers
observational
3
1 country
1
Brief Summary
The purpose of this pilot research is to study brown adipose tissue, a type of fat that increases metabolism (burns energy) during exposure to cold, and how it may contribute to the weight loss observed in cancer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Aug 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 1, 2018
CompletedFirst Posted
Study publicly available on registry
August 8, 2018
CompletedStudy Start
First participant enrolled
August 16, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 20, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
May 20, 2020
CompletedApril 13, 2026
April 1, 2026
1.8 years
August 1, 2018
April 8, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Difference in resting energy expenditure between brown adipose tissue (BAT)-positive and BAT-negative patients with cancer.
Characterization of the energy metabolism profiles of cancer patients with and without evidence of BAT activation will be assessed utilizing one sided t-test.
27 Months
Secondary Outcomes (1)
Difference in energy expenditure between room temperature and response to warm exposure (energy expenditure) in BAT-positive and BAT-negative cancer patients.
27 Months
Study Arms (2)
Brown Adipose Tissue Positive patients
Patients with known malignancy and incidental finding of positron emission tomography/ computerized tomography (PET/CT) scans positive for brown adipose tissue (BAT). After obtaining informed consent and all initial screening visit procedures, patients will participate in two four-hour recording sessions in the whole room indirect calorimeter to assess resting energy expenditure, and patient's thermal (comfort) response to the temperature of the room.
Brown Adipose Tissue Negative Patients
Patients with known malignancy and no evidence of brown adipose tissue BAT activity positron emission tomography/ computerized tomography (PET/CT) scans to be matched to group 1 for primary tumor and stage, sex, age (±5 years), BMI (±3 Kg/m2). After obtaining informed consent and all initial screening visit procedures, patients will participate in two four-hour recording sessions in the whole room indirect calorimeter to assess resting energy expenditure, and patient's thermal (comfort) response to the temperature of the room.
Interventions
During each visit, the participant will be assessed in a resting state in a stable temperature controlled environment, and will undergo tests to find out how the body adjusts its metabolism to different temperatures.
Patients will be given a questionnaire to assess their thermal response (whether they felt warmer or colder) during each study visit.
Eligibility Criteria
Patients equal to or greater than forty years of age with an active cancer diagnosis.
You may qualify if:
- ≥ 40 years of age
- Have active cancer diagnosis.
- Have had a PET/CT scan within the past 12 months at time of enrollment.
- Ability to understand and the willingness to sign a written informed consent document
You may not qualify if:
- Current use of beta-blockers
- Women who are pregnant or unsure of their pregnancy status
- Women who are breastfeeding
- Suffers from severe claustrophobia
- Diagnosed with a serious psychiatric condition which could impede the judgement of the investigators, and/or the successful conduct of the recording.
- In remission stage for cancer diagnosis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Virginia Commonwealth Universitylead
- National Cancer Institute (NCI)collaborator
Study Sites (1)
Virginia Commonwealth University/ Massey Cancer Center
Richmond, Virginia, 23298-0070, United States
MeSH Terms
Conditions
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Francesco S Celi, MD, MHSc
Virginia Commonwealth University
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 1, 2018
First Posted
August 8, 2018
Study Start
August 16, 2018
Primary Completion
May 20, 2020
Study Completion
May 20, 2020
Last Updated
April 13, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share